![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid toxicities that include acute...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.68 | 34.8717948718 | 1.95 | 2.96 | 1.9 | 36516 | 2.69392477 | CS |
4 | 0.54 | 25.8373205742 | 2.09 | 2.96 | 1.8 | 11641 | 2.58454862 | CS |
12 | -0.4599 | -14.8839768277 | 3.0899 | 3.3 | 1.8 | 7702 | 2.61045909 | CS |
26 | 0.1 | 3.95256916996 | 2.53 | 3.3 | 1.8 | 7555 | 2.58383664 | CS |
52 | 0.43 | 19.5454545455 | 2.2 | 4.05 | 1.62 | 10399 | 2.50861958 | CS |
156 | -4.48 | -63.0098452883 | 7.11 | 7.885 | 1.62 | 8153 | 3.60410667 | CS |
260 | -4.75 | -64.3631436314 | 7.38 | 9.33 | 1.62 | 10373 | 4.52908071 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions